Join the Evusheld group to help and get support from people like you.
Evusheld News
Update on US Food and Drug Administration Emergency Use Authorisation of Evusheld
26 January 2023 – The US Food and Drug Administration (FDA) has stated that AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) is not currently authorised for Emergency Use for p...
Evusheld (formerly AZD7442) Long-Acting Antibody Combination Authorised for Emergency Use in the US for Pre-Exposure Prophylaxis (Prevention) of COVID-19
Only antibody therapy authorised in US for pre-exposure prophylaxis Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population AstraZeneca's...
Ask a question
To post your own question to this support group, sign in or create an account.